Removal of this study changed the results of this subgroup, the final result suggested that the DPP-4 inhibitors reduced the relative risk of PCa compared to the control group, which was statistically significant (Z = 2.41, P = .02 < 0.05). Here, DPP4 is linked to posterior cortical atrophy.